Morten Donsmark
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Cardiovascular and renal outcomes of GLP-1 receptor agonists vs. DPP-4 inhibitors and basal insulin in type 2 diabetes mellitus: A systematic review and meta-analysis.
Journal: Diabetes & vascular disease research
Published: December 19, 2023
Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: March 26, 2021
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply.
Journal: The New England journal of medicine
Published: November 21, 2019
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Journal: The New England journal of medicine
Published: June 12, 2019
Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example.
Journal: Diabetes, obesity & metabolism
Published: February 15, 2019
Relationship Between Oral Semaglutide Tablet Erosion and Pharmacokinetics: A Pharmacoscintigraphic Study.
Journal: Clinical pharmacology in drug development
Published: January 28, 2019
Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes.
Journal: Clinical pharmacokinetics
Published: December 20, 2018
Erratum. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program. Diabetes Care 2017;40:839-848.
Journal: Diabetes care
Published: May 27, 2018
Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme.
Journal: Diabetes, obesity & metabolism
Published: September 07, 2015
Is insulin the most effective injectable antihyperglycaemic therapy?
Journal: Diabetes, obesity & metabolism
Published: May 14, 2014
Lixisenatide in the treatment of Type 2 diabetes.
Journal: Expert review of endocrinology & metabolism
Published: May 01, 2014
Last Updated: 09/26/2026